284 related articles for article (PubMed ID: 8605939)
1. Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice.
Ghetie V; Hubbard JG; Kim JK; Tsen MF; Lee Y; Ward ES
Eur J Immunol; 1996 Mar; 26(3):690-6. PubMed ID: 8605939
[TBL] [Abstract][Full Text] [Related]
2. Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1.
Medesan C; Matesoi D; Radu C; Ghetie V; Ward ES
J Immunol; 1997 Mar; 158(5):2211-7. PubMed ID: 9036967
[TBL] [Abstract][Full Text] [Related]
3. Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor.
Kim JK; Tsen MF; Ghetie V; Ward ES
Eur J Immunol; 1994 Oct; 24(10):2429-34. PubMed ID: 7925571
[TBL] [Abstract][Full Text] [Related]
4. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
[TBL] [Abstract][Full Text] [Related]
5. The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn.
Popov S; Hubbard JG; Kim J; Ober B; Ghetie V; Ward ES
Mol Immunol; 1996 Apr; 33(6):521-30. PubMed ID: 8700168
[TBL] [Abstract][Full Text] [Related]
6. Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice.
Israel EJ; Patel VK; Taylor SF; Marshak-Rothstein A; Simister NE
J Immunol; 1995 Jun; 154(12):6246-51. PubMed ID: 7759862
[TBL] [Abstract][Full Text] [Related]
7. Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn- alpha-chain deficient mice.
Kim J; Bronson CL; Wani MA; Oberyszyn TM; Mohanty S; Chaudhury C; Hayton WL; Robinson JM; Anderson CL
Exp Biol Med (Maywood); 2008 May; 233(5):603-9. PubMed ID: 18375831
[TBL] [Abstract][Full Text] [Related]
8. Increasing the serum persistence of an IgG fragment by random mutagenesis.
Ghetie V; Popov S; Borvak J; Radu C; Matesoi D; Medesan C; Ober RJ; Ward ES
Nat Biotechnol; 1997 Jul; 15(7):637-40. PubMed ID: 9219265
[TBL] [Abstract][Full Text] [Related]
9. Localization of the site of the IgG molecule that regulates maternofetal transmission in mice.
Medesan C; Radu C; Kim JK; Ghetie V; Ward ES
Eur J Immunol; 1996 Oct; 26(10):2533-6. PubMed ID: 8898970
[TBL] [Abstract][Full Text] [Related]
10. Mouse MHC class I-like Fc receptor encoded outside the MHC.
Ahouse JJ; Hagerman CL; Mittal P; Gilbert DJ; Copeland NG; Jenkins NA; Simister NE
J Immunol; 1993 Dec; 151(11):6076-88. PubMed ID: 7504013
[TBL] [Abstract][Full Text] [Related]
11. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.
Leach JL; Sedmak DD; Osborne JM; Rahill B; Lairmore MD; Anderson CL
J Immunol; 1996 Oct; 157(8):3317-22. PubMed ID: 8871627
[TBL] [Abstract][Full Text] [Related]
12. Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn.
Kim JK; Firan M; Radu CG; Kim CH; Ghetie V; Ward ES
Eur J Immunol; 1999 Sep; 29(9):2819-25. PubMed ID: 10508256
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of rat IgG to further delineate the Fc:FcRn interaction site.
Medesan C; Cianga P; Mummert M; Stanescu D; Ghetie V; Ward ES
Eur J Immunol; 1998 Jul; 28(7):2092-100. PubMed ID: 9692877
[TBL] [Abstract][Full Text] [Related]
14. Catabolism of the murine IgG1 molecule: evidence that both CH2-CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice.
Kim JK; Tsen MF; Ghetie V; Ward ES
Scand J Immunol; 1994 Oct; 40(4):457-65. PubMed ID: 7939418
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the complex of rat neonatal Fc receptor with Fc.
Burmeister WP; Huber AH; Bjorkman PJ
Nature; 1994 Nov; 372(6504):379-83. PubMed ID: 7969498
[TBL] [Abstract][Full Text] [Related]
16. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.
Petkova SB; Akilesh S; Sproule TJ; Christianson GJ; Al Khabbaz H; Brown AC; Presta LG; Meng YG; Roopenian DC
Int Immunol; 2006 Dec; 18(12):1759-69. PubMed ID: 17077181
[TBL] [Abstract][Full Text] [Related]
17. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta.
Simister NE; Story CM; Chen HL; Hunt JS
Eur J Immunol; 1996 Jul; 26(7):1527-31. PubMed ID: 8766556
[TBL] [Abstract][Full Text] [Related]
18. FcRn mediates elongated serum half-life of human IgG in cattle.
Kacskovics I; Kis Z; Mayer B; West AP; Tiangco NE; Tilahun M; Cervenak L; Bjorkman PJ; Goldsby RA; Szenci O; Hammarström L
Int Immunol; 2006 Apr; 18(4):525-36. PubMed ID: 16481343
[TBL] [Abstract][Full Text] [Related]
19. Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life.
Gurbaxani B; Dela Cruz LL; Chintalacharuvu K; Morrison SL
Mol Immunol; 2006 Mar; 43(9):1462-73. PubMed ID: 16139891
[TBL] [Abstract][Full Text] [Related]
20. Identification of critical IgG binding epitopes on the neonatal Fc receptor.
Vaughn DE; Milburn CM; Penny DM; Martin WL; Johnson JL; Bjorkman PJ
J Mol Biol; 1997 Dec; 274(4):597-607. PubMed ID: 9417938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
